Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About CCCS Interactive Breakdown Better Bets vs. CCCS Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

CCC Intelligent Solutions (CCCS)

Market Price (10/31/2025): $8.74 | Market Cap: $5.6 Bil
Sector: Information Technology | Industry: Application Software

CCC Intelligent Solutions (CCCS)

Market Price (10/31/2025): $8.74
Market Cap: $5.6 Bil
Sector: Information Technology
Industry: Application Software

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 28%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 23%		 Weak multi-year price returns
2Y Excs Rtn is -85%, 3Y Excs Rtn is -79%		 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 86x, P/EPrice/Earnings or Price/(Net Income) is 2901x
1 Low stock price volatility
Vol 12M is 29%		  Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -4.5%
0 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 28%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 23%
1 Low stock price volatility
Vol 12M is 29%
2 Weak multi-year price returns
2Y Excs Rtn is -85%, 3Y Excs Rtn is -79%
3 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 86x, P/EPrice/Earnings or Price/(Net Income) is 2901x
4 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -4.5%

Market Valuation & Key Metrics

CCCSS&P 500
REVENUE GROWTHGOOD
Rev LTM ($ Bil)1.0
Rev Chg Q12.0%6.4%
Rev Chg LTM9.6%5.4%
Rev Chg 3Y Avg10.3%5.3%
PROFITABILITYPOOR
Op Inc LTM ($ Bil)0.1
CFO LTM ($ Bil)0.3
Net Inc LTM ($ Bil)0.0
Op Mgn LTM6.4%18.7%
CFO/Rev LTM27.9%20.4%
Net Inc Mgn0.2%12.8%
VALUATIONMODERATE
P/S5.63.2
P/CFO20.015.5
P/FCF24.620.6
P/E2,897.823.6
STABILITYGOOD
Debt/Equity0.190.21
Cash/Assets0.020.07

CCCS Stock

   
   
   
   
   
   
   
Factor Drivers of Stock Movement
The -4.7% change in CCCS stock from 5/1/2025 to 10/30/2025 was primarily driven by a -93.0% change in the company's Net Income Margin (%).

501202510302025Change
Stock Price ($)9.188.75-4.68%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)944.80996.965.52%
Net Income Margin (%)2.77%0.19%-93.03%
P/E Multiple217.282901.101235.18%
Shares Outstanding (Mil)618.83637.58-3.03%
Cumulative Contribution-4.77%

LTM = Last Twelve Months as of date shown
The -17.5% change in CCCS stock from 10/30/2024 to 10/30/2025 was primarily driven by a -96.2% change in the company's Net Income Margin (%).

1030202410302025Change
Stock Price ($)10.618.75-17.53%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)926.94996.967.55%
Net Income Margin (%)5.02%0.19%-96.16%
P/E Multiple140.502901.101964.88%
Shares Outstanding (Mil)615.86637.58-3.53%
Cumulative Contribution-17.63%

LTM = Last Twelve Months as of date shown
The -6.2% change in CCCS stock from 10/31/2022 to 10/30/2025 was primarily driven by a -86.2% change in the company's Net Income Margin (%).

1031202210302025Change
Stock Price ($)9.338.75-6.22%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)647.72996.9653.92%
Net Income Margin (%)1.40%0.19%-86.23%
P/E Multiple611.592901.10374.35%
Shares Outstanding (Mil)594.55637.58-7.24%
Cumulative Contribution-6.71%

LTM = Last Twelve Months as of date shown

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
CCCS Return--14%-24%31%3%-25%-31%
Peers Return13%-2%-7%6%52%-19%35%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
CCCS Win Rate100%50%42%50%42%44% 
Peers Win Rate13%10%5%21%33%48% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
CCCS Max Drawdown--33%-34%-4%-12%-29% 
Peers Max Drawdown-5%-4%-8%-1%-4%-34% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: ADSK, HIT, BIYA, BLIV, BMR.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

Unique KeyEventCCCSS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-48.6%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven94.7%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-7.1%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven7.6%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven26 days148 days

Compare to ADSK, HIT, BIYA, BLIV, BMR


In The Past

CCC Intelligent Solutions's stock fell -48.6% during the 2022 Inflation Shock from a high on 1/25/2021. A -48.6% loss requires a 94.7% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About CCC Intelligent Solutions (CCCS)

Better Bets than CCC Intelligent Solutions (CCCS)

 CCCSBetter Performance than CCCS
MetricValueIndustry (Application Software)
Rev Chg LTM9.6%ORCL (9.7%), PLTR (38.8%), SAP (9.7%), SHOP (29.0%), INTU (15.6%)
Rev Chg 3Y Avg10.3%PLTR (25.7%), CRM (10.5%), SHOP (26.0%), INTU (14.0%), ADBE (10.5%)
Op Mgn LTM6.4%ORCL (31.6%), PLTR (16.6%), SAP (26.4%), CRM (21.2%), SHOP (15.3%)
CFO/Rev LTM27.9%ORCL (36.5%), PLTR (50.3%), CRM (33.3%), INTU (33.0%), ADBE (42.2%)
FCF/Rev LTM22.7%PLTR (49.7%), CRM (31.6%), INTU (32.3%), ADBE (41.4%), CDNS (28.4%)
Total Yield0.0%ORCL (2.4%), PLTR (0.2%), SAP (2.3%), CRM (3.2%), SHOP (1.0%)
 CCCSBetter Performance than CCCS
MetricValueAll Other Sectors
Rev Chg LTM9.6%GOOGL (13.4%), AMZN (10.9%), META (21.3%), LLY (36.8%), V (11.4%)
Rev Chg 3Y Avg10.3%GOOGL (11.0%), AMZN (11.3%), META (17.3%), JPM (13.5%), LLY (23.4%)
Op Mgn LTM6.4%GOOGL (32.2%), AMZN (11.4%), META (43.2%), LLY (43.0%), V (66.5%)
CFO/Rev LTM27.9%GOOGL (39.3%), META (56.8%), V (60.4%), MA (53.3%), ABBV (33.1%)
FCF/Rev LTM22.7%META (23.7%), V (56.8%), MA (49.2%), ABBV (31.3%), AXP (26.9%)
Total Yield0.0%GOOGL (3.9%), AMZN (3.0%), META (3.8%), TSLA (0.4%), JPM (6.6%)
 Best Bets In Information Technology Sector
 CCCSVRSN NVDA RMBS QLYS ADBE YOU GEN IDCC DBX KLAC
What You Pay           
P/E2901.127.157.150.724.320.616.527.022.216.139.5
P/EBIT86.219.649.043.222.716.519.69.917.713.732.4
What You Get           
Rev Chg Q12.0%7.3%55.6%22.7%10.3%10.7%17.5%30.3%34.5%-1.4%23.6%
Rev Chg LTM9.6%5.5%71.6%31.0%9.6%10.7%19.8%10.6%21.8%-0.0%23.9%
Rev Chg 3Y Avg10.3%5.2%92.0%17.3%12.5%10.5%35.5%14.8%23.3%4.1%10.4%
FCF/Rev 3Y Avg21.4%57.4%41.3%39.3%39.0%37.7%37.3%35.9%35.1%32.9%31.1%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 24%, alpha of 2.9%, and sharpe of 1.04

Latest Trefis Analyses

TitleTopic
0DASHBOARDS 
1CCC Intelligent Solutions Earnings Notes 
2How Low Can CCC Intelligent Solutions Stock Really Go?Return
3CCC Intelligent Solutions vs Microsoft: Which Is A Better Investment?Counter-Intuitive Comparisons
4CCC Intelligent Solutions vs Cadence Design Systems: Which Is A Better Investment?Counter-Intuitive Comparisons
5Better Bet Than CCCS Stock: Pay Less Than CCC Intelligent Solutions To Get More From NVDA, AMZN  
6Better Bet Than CCCS Stock: Pay Less Than CCC Intelligent Solutions To Get More From NVDA, MU  
7Better Bet Than CCCS Stock: Pay Less Than CCC Intelligent Solutions To Get More From WDAY, BSY  
8CCC Intelligent Solutions (CCCS) EBITDA ComparisonFinancials
9CCC Intelligent Solutions (CCCS) Debt ComparisonFinancials
10CCC Intelligent Solutions (CCCS) Revenue ComparisonFinancials

Trade Ideas

Select past ideas related to CCCS. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADBE_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025ADBEAdobeMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-4.2%-4.2%-6.7%
CRM_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025CRMSalesforceMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		6.1%6.1%-0.6%
MPWR_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025MPWRMonolithic Power SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		18.8%18.8%-1.8%
POWI_9262025_Dip_Buyer_High_CFO_Margins_ExInd_DE09262025POWIPower IntegrationsDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap		3.7%3.7%-13.4%
ROP_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025ROPRoper TechnologiesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-10.5%-10.5%-10.5%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADBE_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025ADBEAdobeMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-4.2%-4.2%-6.7%
CRM_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025CRMSalesforceMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		6.1%6.1%-0.6%
MPWR_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025MPWRMonolithic Power SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		18.8%18.8%-1.8%
POWI_9262025_Dip_Buyer_High_CFO_Margins_ExInd_DE09262025POWIPower IntegrationsDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap		3.7%3.7%-13.4%
ROP_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025ROPRoper TechnologiesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-10.5%-10.5%-10.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for CCC Intelligent Solutions

Financials

CCCSADSKHITBIYABLIVBMRMedian
NameCCC Inte.Autodesk Health I.Baiya In.BeLive Beamr Im. 
Mkt Price8.75300.772.610.303.602.593.10
Mkt Cap5.664.10.1---5.6
Rev LTM9976,60527---997
Op Inc LTM641,5151---64
FCF LTM2261,8471---226
FCF 3Y Avg1961,704----950
CFO LTM2781,9254---278
CFO 3Y Avg2491,775----1,012

Growth & Margins

CCCSADSKHITBIYABLIVBMRMedian
NameCCC Inte.Autodesk Health I.Baiya In.BeLive Beamr Im. 
Rev Chg LTM9.6%13.8%29.7%---13.8%
Rev Chg 3Y Avg10.3%11.7%----11.0%
Rev Chg Q12.0%17.1%86.2%---17.1%
QoQ Delta Rev Chg LTM2.9%4.1%19.3%---4.1%
Op Mgn LTM6.4%22.9%5.0%---6.4%
Op Mgn 3Y Avg6.6%21.5%----14.0%
QoQ Delta Op Mgn LTM0.0%0.8%-0.1%---0.0%
CFO/Rev LTM27.9%29.1%13.5%---27.9%
CFO/Rev 3Y Avg27.4%30.7%----29.0%
FCF/Rev LTM22.7%28.0%4.9%---22.7%
FCF/Rev 3Y Avg21.4%29.5%----25.5%

Valuation

CCCSADSKHITBIYABLIVBMRMedian
NameCCC Inte.Autodesk Health I.Baiya In.BeLive Beamr Im. 
Mkt Cap5.664.10.1---5.6
P/S5.69.75.4---5.6
P/EBIT86.245.373.1---73.1
P/E2,901.161.4106.2---106.2
P/CFO20.033.340.2---33.3
Total Yield0.0%1.6%0.9%---0.9%
Dividend Yield0.0%0.0%0.0%---0.0%
FCF Yield 3Y Avg3.0%3.3%----3.1%
D/E0.20.00.0---0.0
Net D/E0.20.0-0.1---0.0

Returns

CCCSADSKHITBIYABLIVBMRMedian
NameCCC Inte.Autodesk Health I.Baiya In.BeLive Beamr Im. 
1M Rtn-4.0%-5.3%-18.7%-48.0%-1.1%-15.4%-10.3%
3M Rtn-9.5%-0.8%26.1%-56.5%36.4%-14.8%-5.1%
6M Rtn-4.7%10.0%328.6%-93.3%-18.0%5.3%0.3%
12M Rtn-17.5%4.1%----20.2%-17.5%
3Y Rtn-6.2%40.3%----17.1%
1M Excs Rtn-4.4%-6.4%-21.8%-50.8%-4.9%-16.7%-11.6%
3M Excs Rtn-19.4%-8.1%21.1%-65.8%43.8%-23.6%-13.8%
6M Excs Rtn-26.4%-11.8%306.8%-115.1%-39.7%-16.5%-21.4%
12M Excs Rtn-37.2%-12.2%----41.0%-37.2%
3Y Excs Rtn-79.1%-37.4%-----58.2%

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date7/31/20255/6/20252/25/202510/28/20247/30/20244/30/20242/28/202411/6/20238/1/20235/2/20233/1/202311/4/2022
Key Financials Quarterly            
Total Revenue260252246238233227229221212205204199
Ebitda6023575872468830-52494655
Operating Income24-11212923819179131017
Net Income13-195320-225-22-982110
EPS0.02-0.030.010.000.030.000.04-0.04-0.160.000.000.02
Key Financials TTM            
Total Revenue TTM997969945927910889866842819801782765
Ebitda TTM1982102332632351111147298215216179
Operating Income TTM646280786653584949535258
Net Income TTM29264721-96-92-117-852938-21
Growth Rates Quarterly            
Total Revenue Growth12.0%10.7%7.8%7.8%9.9%10.9%12.0%11.3%9.8%9.7%9.1%12.5%
EBITDA Growth-16.4%-50.3%-34.9%94.2%238.2%-7.4%92.0%-46.0%-180.1%-1.7%418.5%128.0%
Operating Income Growth8.7%-237.2%9.0%73.1%146.7%-41.5%99.7%-2.8%-27.1%5.3%-36.6%109.0%
Net Income Growth-35.9%-975.2%-80.8%112.7%120.7%-179.6%2251.8%-326.8%-727.5%-81.8%101.9%105.2%
Margins Quarterly            
EBITDA Margin23.1%9.0%23.1%24.3%31.0%20.1%38.3%13.5%-24.6%24.0%22.3%27.8%
Operating Income Margin9.4%-4.3%8.6%12.0%9.7%3.4%8.5%7.5%4.3%6.5%4.7%8.6%
Net Income Margin5.0%-7.4%2.0%1.2%8.7%-0.8%11.0%-10.0%-46.1%1.1%0.5%4.9%
Cash & Debt            
Total Cash55130399286238191196449404338324248
Total Debt1,0681,048824826828831833836838841842846
Net Debt / (Cash)1,013918425540590640638387435502518597
Cash Flows Quarterly            
FCF from Operations4358114635255876170338131
Cash Flows TTM            
FCF from Operations TTM278287284257254272250245215186200149
Returns to Shareholders Quarterly            
Dividends000000000000
Share Repurchases10072-0-0-0-0-0-0-0-0-0-0
Return on Invested Capital (ROIC) Quarterly            
ROIC2.2%-0.6%1.5%1.0%2.1%0.1%1.7%2.0%1.1%1.6%1.2%1.5%
Return on Invested Capital (ROIC) TTM            
ROIC TTM1.4%1.1%1.6%1.7%1.4%1.5%1.6%1.5%1.5%1.1%1.2%1.7%

Price Behavior

CCCS Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta0.05-0.180.210.710.730.71
Up Beta1.94-0.08-0.070.820.780.61
Down Beta3.29-0.02-0.310.480.580.72
Up Capture-126%-41%23%57%47%34%
Bmk +ve Days13233574144420
Stock +ve Days6192960115357
Down Capture16%3%76%92%97%96%
Bmk -ve Days8192952107330
Stock -ve Days15233463131373

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity41,102,291
Short Interest: % Change Since 9302025-6.2%
Average Daily Volume5,026,569
Days-to-Cover Short Interest8.18
Basic Shares Quantity637,578,033
Short % of Basic Shares6.4%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/31/20250.6%0.4%2.4%
5/6/2025-9.7%-1.1%-3.6%
2/25/20250.1%-6.2%-11.6%
10/28/2024-0.2%-2.6%15.3%
7/30/2024-7.0%-9.0%-2.6%
2/28/20240.9%2.2%3.1%
11/6/20237.0%3.5%6.8%
8/1/2023-2.0%-3.9%-3.0%
...
SUMMARY STATS   
# Positive867
# Negative687
Median Positive1.4%3.0%3.1%
Median Negative-2.7%-2.4%-3.0%
Max Positive8.4%12.5%22.3%
Max Negative-9.7%-9.0%-11.6%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025731202510-Q 6/30/2025
3312025506202510-Q 3/31/2025
12312024225202510-K 12/31/2024
93020241028202410-Q 9/30/2024
6302024730202410-Q 6/30/2024
3312024430202410-Q 3/31/2024
12312023228202410-K 12/31/2023
93020231106202310-Q 9/30/2023
6302023801202310-Q 6/30/2023
3312023502202310-Q 3/31/2023
12312022301202310-K 12/31/2022
93020221104202210-Q 9/30/2022
6302022805202210-Q 6/30/2022
3312022506202210-Q 3/31/2022
12312021301202210-K 12/31/2021
93020211112202110-Q 9/30/2021

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value		Value of
Held Shares		Form
0GOODSON JOHN PAGESee Remarks9082025Sell9.7942,531416,4341,541,914Form
1Wei Eric 8082025Sell9.8722,005,957217,231,805270,399,476Form
2Young Lauren 8082025Sell9.8722,005,957217,231,805270,399,476Form
3ADVENT INTERNATIONAL, L.P. 8082025Sell9.8722,005,957217,231,805270,399,476Form
4Young Lauren 5222025Sell9.0822,005,957199,814,090448,532,850Form

External Quote Links


Prefer one of these to Trefis? Tell us why.